The brain implant revolution is here. Why is its inventor terrified? He should be as God is not given a mention by any of the workers in this space. It is just another sign we are in the prophesied Biblical end-times prior to Jesus return to set up His Millennial reign on this Earth.

Jesus and the resurrected Saints will rule the nations with a rod of iron so we can be sure new technologies such as Brain Computer Interface (BCI) will be used wisely if at all. We were made by God to work and be creative, after all, we are made in His image. Hence, we will use the technologies that God has put there for us to creatively use. I am confident that Nuclear Fission will be used in Jesus Millennial Kingdom as a base load power source.

Australian neurologist Tom Oxley (picture), the co-inventor of the world’s most innovative brain-computer interface (BCI) is at the forefront of the world’s progression towards cognitive artificial intelligence. Oxley says, “It’s phenomenal. The next couple of decades are going to be very hard to predict. And every day, I’m increasingly thinking that BCIs are going to have more of an impact than anyone realises.”

Brain-computer interfaces are tiny devices inserted directly into the brain, where they pick up electrical signals and transmit them to an external computer or device where they are ­decoded algorithmically. The subject of a cover story in the Australian in 2023, a BCI called the Stentrode, developed at the University of ­Melbourne by Oxley’s company, Synchron, is inserted into the brain non-invasively through the jugular vein.

In 2022, Synchron, which initially received funding from the US Defense Advanced ­Research Projects Agency (DARPA) and the Australian Government, and later attracted ­investment from the likes of Bill Gates and Jeff Bezos, had become the first company in the world to be approved by the US Food and Drug Administration to conduct a human trial of its BCI in the US – outpacing Elon Musk’s company Neuralink, which is operating in the same space. Since then the Stentrode has been implanted into 10 people with neurodegenerative disease, enabling them to control devices such as computers and phones with their thoughts.

A seismic development in Synchron’s ­evolution occurred in March, when Oxley ­announced a partnership between the company and chipmaking giant Nvidia, to build an AI brain foundation model that learns directly from neural data. The model, dubbed Chiral, connects Syncron’s BCI – developed in Melbourne – with Nvidia’s AI computing platform Holoscan, which allows developers to build AI streaming apps that can be displayed on Apple’s Vision Pro spatial computer, the tech giant’s early foray into extended reality.

“A core human drive, encoded in our DNA, is to improve our condition,” says Oxley, a professorial fellow at the University of Melbourne’s department of medicine and now based in New York City. “For patients with neurological ­injury, this means restoring function. In the ­future, it seems inevitable that it will include enhancement [in the wider population].

BCIs will enable us to go beyond our physical limitations, to express, connect and create better than ever before. Neurotechnology should be a force for wellbeing, expanding human potential and improving quality of life.” But the collision of the development of BCIs with the now-supercharged development of AI has ramifications almost beyond imagining.